Membrane-bound form of fractalkine induces IFN- production by NK cells

European Journal of Immunology

Volumn 33, Issue 1, 2003, Pages 53-58

  Yoneda, Osamu ^a,b   Imai, Toshio ^c   Nishimura, Miyuki ^c   Miyaji, Michihiko ^d   Mimori, Tsuneyo ^d   Okazaki, Toshiro ^d   Domae, Naochika ^a   Fujimoto, Hiroko ^b   Minami, Yasuhiro ^b   Kono, Takeshi ^e   Bloom, Eda T ^f   Umehara, Hisanori ^d  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kan Research Institute ^*  (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Kawanishi Pharma Res Inst   (Japan)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Chemokine; Cytokine; Fractalkine; IFN ; NK cell

Indexed keywords

CHEMOKINE; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; HERBIMYCIN A; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RANTES; WORTMANNIN;

CELL ACTIVATION; CELL POLARITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MEMBRANE BINDING; NATURAL KILLER CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL;

CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; CHEMOKINES, CX3C; COCULTURE TECHNIQUES; ENZYME INHIBITORS; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; PROTEIN BINDING; TRANSFECTION;

EID: 0037258290     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/immu.200390007     Document Type: Review

References (41)

1. Moretta, L., Ciccone, E., Mingari, M. C., Biassoni, R. and Moretta, A., Human natural killer cells: origin, clonality, specificity, and receptors. Adv. Immunol. 1993. 55: 341-380.
2. Lanier, L. L., Corliss, B. and Phillips, J., Arousal and inhibition of human NK cells. Immunol. Rev. 1997. 155: 145-154.
3. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P., Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999. 17: 189-220.
4. Guidotti, L. G. and Chisari, F. V., Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001. 19: 65-91.
5. Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwarts, B. S., Marnathan, E. S., McCrae, K. R., Hug, B. A., Schmidt, A.-M. and Stern, D. M., Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998. 91: 3527-3561.
6. Montovani, A., Bussolino, F. and Introna, M., Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today 1997. 18: 231-240.
7. Sallusto, F., Lanzavecchia, A. and Mackay, C. R., Chemokines and chemokine receptors in T cell priming and Th1/Th2-medaited responses. Immunol. Today 1998. 19: 568-574.
8. Rengarajan, J., Szabo, S. J. and Glimcher, L. H., Transcriptional regulation of Th1/Th2 polarization. Immunol. Today 2000. 21: 479-483.
9. Rossi, D. and Zlontnik, A., The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000. 18: 217-242.
10. Baggiolini, M., Dewald, B. and Moser, B., Human chemokines: an update. Annu. Rev. Immunol. 1997. 15: 675-705.
11. Rollins, B. J., Chemokines. Blood 1997. 90: 909-928.
12. Zlontnik, A. and Yoshie, O., Chemokines: a new classification system and their role in immunity. Immunity 2000. 12: 121-127.
13. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Ross, D., Greaves, D. R., Zlotnik, A. and Schall, T. J., A new class of membrane-bound chemokine with a CX3C motif. Nature 1997. 385: 640-644.
14. Pan, Y., Lioyd, C., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J.-A., Vath, J., Gosselin, M., Ma, J., Dussault, B., Woolf, E., Alperin, G., Culpepper, J., Gutierrez-Ramos, J. C. and Gearing, D., Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997. 387: 611-617.
15. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J. and Yoshie, O., Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997. 91: 521-530.
16. Yoneda, O., Imai, T., Gouda, S., Inoue, H., Yamauchi, A., Okazaki, T., Yoshie, O., Domae, N. and Umehara, H., NK cell-mediated vascular injury. J. Immunol. 2000. 164: 4055-4062.
17. Umehara, H., Bloom, E. T., Okazaki, T., Domae, N. and Imai, T., Fractalkine and vascular injury. Trends Immunol. 2001. 22: 602-607.
18. Scott, P. and Trinchieri, G., The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 1995. 7: 34-40.
19. Seaman, W. E., Natural killer cells and natural killer T cells. Arthritis Rheum. 2000. 43: 1204-1217.
20. Taub, D. D., Sayers, T. J., Carter, C. R. D. and Ortaldo, J. R., Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 1995. 155: 3877-3888.
21. 2+ mobilization, and enzyme release. J. Immunol. 1996. 156: 322-327.
22. Maghazachi, A. A., Chemokines, G proteins and natural killer cells. Arch. Immunol. Ther. Exp. 2000. 48: 65-72.
23. Goda, S., Imai, T., Yoshie, O., Yoneda, O., Inoue, H., Nagano, Y., Okazaki, T., Imai, H., Bloom, E. T., Domae, N. and Umehara, H., CX3C-chemokine, fractalkine enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and independent mechanisms. J. Immunol 2000. 164: 4313-4320.
24. Umehara, H., Goda, S., Imai, T., Nagano, Y., Minami, Y., Tanaka, Y., Okazaki, T., Bloom, E. T. and Domae, N., Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol. Cell Biol. 2001. 79: 298-302.
25. Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T. and Patel, D., Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 1998. 188: 1413-1419.
26. Haskell, C. A., Cleary, M. D. and Charo, I. F., Unique role of the chemokine domain of fractalkine in cell capture. J. Biol. Chem. 2000. 275: 34183-34189.
27. Rodriguez-Frade, J. M., Mellado, M. and Martinez-A, C., Chemokine receptor dimerization: two are better than one. Trends Immunol. 2001. 22: 612-617.
28. Al-Aoukaty, A., Rolstad, B., Giaid, A. and Maghazachi, A. A., MIP-3α, MIP-3β and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells. Immunology 1998. 95: 618-624.
29. Cambien, B., Pomeranz, M., Schmid-Antomarchi, H., Millet, M.-A., Breittmayer, V., Rossi, B. and Schmid-Alliana, A., Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 2001. 97: 2031-2037.
30. Meucci, O., Fatatis, A., Simen, A. A. and Miller, R. J., Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 2000. 97: 8075-8080.
31. Rickert, P., Weiner, O. D., Wang, F., Bourne, H. R. and Servant, G., Leukocytes navigate by compass: roles of PI3Kγ and its lipid products. Trends Cell Biol. 2000. 10: 466-473.
32. D'Ambrosio, D., Iellem, A., Colantonio, L., Clissi, B., Pardi, R. and Sinigaglia, F., Localization of Th-cell subsets in inflammation: differential thresholds for extravasation of Th1 and Th2 cells. Immunol. Today 2000. 21: 183-186.
33. Yoshie, O., Imai, T. and Nomiyama, H., Related article chemokines in immunity. Adv. Immunol. 2001. 78: 57-110.
34. Fraticelli, P., Sironi, M., Bianchi, G., D'Ambrosio, D., Albanesi, C., Stoppacciaro, A., Chieppa, M., Allavena, P., Ruco, L., Girolomoni, G., Sinigaglia, F., Vecci, A. and Mantovani, A., Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 2001. 107: 1173-1181.
35. Mosmann, T. R. and Sad, S., The expanding universe of T cell subsets: Th1, Th2 and more. Immunol. Today 1996. 17: 138-146.
36. Jankovic, D., Liu, S. and Gauss, W. C., Th1- and Th2-cell commitment during infections disease: asymmetry in divergent pathways. Trends Immunol. 2001. 22: 450-457.
37. Kourilsky, P. and Truffa-Bachi, P., Cytokine fields and the polarization of the immune response. Trends Immunol. 2001. 22: 502-509.
38. Nishimura, M., Umehara, H., Nakayama, T., Yoneda, O., Hieshima, K., Kakizaki, M., Domae, N., Yoshie, O. and Imai, T., Dual functions of fractalkine/CX3CR1 in trafficking of circulating cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 2002. 168: 6173-6180.
39. Faure, E., Thomas, L., Xu, H., Medvedev, A. E., Equils, O. and Arditi, M., Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J. Immunol. 2001. 166: 2018-2024.
40. Mantovani, A., The chemokine system: redundancy for robust output. Immunol. Today 1999. 20: 254-257.
41. Umehara, H., Takashima, A., Minami, Y. and Bloom, E. T., Signal transduction via phosphorylated adhesion molecule, LFA-1β (CD18), is increased by culture of natural killer cells with IL-2 in the generation of lymphokine-activated killer cells. Int. Immunol. 1992. 5: 19-27.